Chargement en cours...
Opioid Antagonists for Pharmacological Treatment of Gambling Disorder: Are they Relevant?
BACKGROUND: To date, no drugs have been approved for gambling disorder. Numerous publications have described the value of opioid antagonists. Indeed, the mesocorticolimbic dopaminergic pathway has been suggested as the underlying cause of reward-seeking behaviour, and it is modulated by the opioid s...
Enregistré dans:
| Publié dans: | Curr Neuropharmacol |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Bentham Science Publishers
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6295935/ https://ncbi.nlm.nih.gov/pubmed/28721822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X15666170718144058 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|